BRIACELL THERAP (BCTX) vs Seres Therapeutics, Inc. (MCRB)
BRIACELL THERAP and Seres Therapeutics, Inc. are both Biotechnology companies. BRIACELL THERAP and Seres Therapeutics, Inc. are of similar size ($37.2M and $36.0M). Seres Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; BRIACELL THERAP trades at 1.9×. BRIACELL THERAP has the higher net margin (0.00% vs −1,192.9%) and the lower return on invested capital (−3,311.0% vs −277.3%). Across the 13 metrics below, Seres Therapeutics, Inc. leads on 7 and BRIACELL THERAP on 6.
Valuation
Profitability
| Metric | BCTX | MCRB | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (4,462.77%) | 0.00% |
| Net margin | 0.00% | (1,192.94%) | 0.00% |
| Free cash flow margin | 0.00% | (2,721.83%) | 0.00% |
| Return on equity | (173.55%) | (66.57%) | (57.72%) |
| Return on assets | (139.20%) | (18.31%) | (49.22%) |
| Return on invested capital | (3,311.00%) | (277.30%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack